These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 6311293)

  • 1. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.
    Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet [3H]imipramine binding in psychiatric disorders.
    Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
    Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
    Egrise D; Desmedt D; Schoutens A; Mendlewicz J
    Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects.
    Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R
    Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3H-imipramine binding sites in platelets from psychiatric patients.
    Mellerup ET; Plenge P; Rosenberg R
    Psychiatry Res; 1982 Oct; 7(2):221-7. PubMed ID: 6959172
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 10. WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study.
    Bech P; Eplov L; Gastpar M; Gentsch C; Mendlewicz J; Plenge P; Rielaert C; Mellerup ET
    Pharmacopsychiatry; 1988 May; 21(3):147-50. PubMed ID: 2841696
    [No Abstract]   [Full Text] [Related]  

  • 11. Tritiated imipramine binding to platelets in manic subjects.
    Lewis DA; McChesney C
    J Affect Disord; 1985 Nov; 9(3):207-11. PubMed ID: 3001164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
    Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
    Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet 3H-imipramine binding in bipolar patients.
    Muscettola G; Di Lauro A; Giannini CP
    Psychiatry Res; 1986 Aug; 18(4):343-53. PubMed ID: 3018819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of imipramine platelet binding sites as a biological marker of endogenous depression. A World Health Organization Collaborative Study.
    Pharmacopsychiatry; 1990 May; 23(3):113-7. PubMed ID: 2165264
    [No Abstract]   [Full Text] [Related]  

  • 16. [3H] imipramine binding sites are decreased in platelets of chronic pain patients.
    Magni G; Andreoli F; Arduino C; Arsie D; Ceccherelli F; Ambrosio F; Eandi M
    Acta Psychiatr Scand; 1987 Jan; 75(1):108-10. PubMed ID: 3033997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet imipramine binding in depressed children and adolescents.
    Ambrosini PJ; Metz C; Arora RC; Lee JC; Kregel L; Meltzer HY
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):298-305. PubMed ID: 1314256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-Imipramine binding sites in platelets of hospitalized psychiatric patients.
    Gentsch C; Lichtsteiner M; Gastpar M; Gastpar G; Feer H
    Psychiatry Res; 1985 Mar; 14(3):177-87. PubMed ID: 2988002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.